Safety Study of the VEGA UV-A System to Treat Ectasia

Phase 3 Terminated 103 enrolled Topcon Medical Systems, Inc.

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research study is to test the safety, tolerability, and effectiveness of corneal collagen cross-linking (CXL) when used to treat ectasia.

Timeline

Start: 2010-12
Primary completion: 2012-07
Completion: 2012-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	Riboflavin	Other / unclassified	—	—

Safety Study of the VEGA UV-A System to Treat Ectasia

Summary

Timeline

Drugs

Indications